Willow vs Wellorithm: Telehealth GLP-1 Programs Compared

Quick verdict: Willow emphasizes oral GLP-1 plus progress tracking and follow-up support, while Wellorithm focuses on broader compound options and licensed clinicians in all 50 states. Willow vs Wellorithm centers on support model, medication types, pricing transparency, clinician coverage, and shipping.

Explore Willow’s structured GLP-1 program

Head-to-head summary: support model and scope

Willow positions its oral GLP-1 program as a structured weight management journey that emphasizes progress tracking tools and follow-up consultations with a licensed telehealth team. Wellorithm is a telehealth GLP-1 platform offering compounded semaglutide and tirzepatide, with licensed clinicians in all 50 states and virtual consultations that result in medication shipped to your home. Treatment from both providers is available only when a licensed clinician determines it is medically appropriate.

Distinctive differences we compare

• Support and tracking: Willow highlights progress tracking and follow-up; Wellorithm emphasizes virtual consultations and shipping.
• Medication types: Willow presents oral GLP-1; Wellorithm offers compounded semaglutide and tirzepatide (injections and oral dissolving tablets).
• Pricing and transparency: Willow shows a starting price of 299; Wellorithm advertises starting options like $147 and other starting figures but does not publish full pricing without an intake.
• Clinician coverage: Willow uses a licensed telehealth team; Wellorithm specifically notes licensed clinicians in all 50 states.
• Regulatory and compounding notes: Both state that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality when applicable.

Comparison table: Willow vs Wellorithm

Criteria	Willow	Wellorithm
Starting price	299	Only $147 + Fast, Free Shipping; other starting figures shown but personalized quote often required
Medication types	Oral GLP-1 program (telehealth-first)	Compounded semaglutide and tirzepatide; injections and oral dissolving tablets noted
Support and follow-up	Progress tracking tools and follow-up consultations with licensed telehealth team	Virtual consultations and ongoing virtual check-ins; medication shipped to home
Clinician coverage	Licensed telehealth team (coverage details not published)	Licensed clinicians in all 50 states
Regulatory note	Compounded medications, when offered, are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality	Compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality

Support and follow-up: structured program versus virtual check-ins

Willow positions its offering as a structured weight management journey with progress tracking tools and follow-up consultations designed to convert GLP-1 efficacy into sustained behavior change. Wellorithm delivers fully virtual consultations and ongoing virtual check-ins to keep titration on track and ships medication to your home. If structured digital follow-up is a priority, Willow highlights that as a core feature. If fully virtual access and shipped medication are primary concerns, Wellorithm emphasizes those elements.

View Willow’s progress tracking and follow-up

Medication options and regulatory notes

Wellorithm explicitly offers compounded semaglutide and tirzepatide, including injection and oral dissolving tablet formats. Willow presents an oral GLP-1 program but captured evidence does not list multiple compounded options. Both providers include the qualifier that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. Treatment from either provider is subject to clinician review and determined medically appropriate.

Pricing and transparency

Willow lists a starting price of 299, described in the source as 299. Wellorithm advertises entry points such as Only $147 + Fast, Free Shipping and other starting figures across product types, but the platform also notes that pricing details and personalized quotes may be provided after intake. Wellorithm’s FAQ captured that they do not publish complete pricing on the site and you receive a personalized quote after the intake quiz.

Check Wellorithm’s eligibility quiz and pricing

Clinician coverage and access

Wellorithm highlights licensed clinicians in all 50 states, which the source frames as a meaningful advantage for patients in states with limited GLP-1 telehealth options. Willow is described as telehealth-first with a licensed telehealth team, but the captured evidence does not specify nationwide clinician coverage.

See Wellorithm’s national clinician coverage

Conclusion: Choose based on support, medication breadth, and access

Willow vs Wellorithm shows clear trade-offs. Choose Willow if you want a structured oral GLP-1 program that emphasizes progress tracking tools and follow-up consultations as part of a weight management journey. Choose Wellorithm if you need access to compounded semaglutide and tirzepatide with licensed clinicians in all 50 states and fully virtual medication delivery. Treatment from both providers is available only when a licensed clinician determines it is medically appropriate, and compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality.